Yvonne Henskens (Y.M.C.)

Nieuwenstein, T., Stoffer, I. P., Hellenbrand, D. L. S., Mathot, R. A. A., van Pelt, L. J., Pequeriaux, N. C. V., van de Kerkhof, D., Kuijper, P. H. M., Zant, J. C., Garnier, D. A. J., Schindhelm, R. K., Hamer, H. M., van Duijnhoven, H. L. P., Bosman, M. C. J., Jeninga, E. H., de Kok, J. B., Schellings, M. W. M., Waals-Prinzen, L., Rijpma, S. R., ... Stroobants, A. K. (2026). Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays. Clinical Chemistry and Laboratory Medicine, 64(11), 2590-2601. https://doi.org/10.1515/cclm-2026-0026

Wang, S. J., van Meel, R. A. J. N., Mestrum, S. G. C., Habets, T. H. P. M., Hopman, A. H. N., Ramaekers, F. C. S., Henskens, Y. M. C., Bekers, O., & Leers, M. P. G. (2026). Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy. Cancers, 18(16), Article 2648. https://doi.org/10.3390/cancers18162648

Stroobants, A. K., Gottgens, E.-L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300

van Dam, A. D., Bioch, M. M., Jeninga, E. H., de Kok, J. B., Rijpma, S. R., Thelen, M. H. M., Henskens, Y. M. C., van Oerle, R. G. M., Stroobants, A. K., & Coagulation Section of the Dutch Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML) (2026). Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements. Thrombosis Research, 263, Article 109771. https://doi.org/10.1016/j.thromres.2026.109771

Derikx, F., Merry, I., Willemsen, D., Beckers, E., Henskens, Y., & Heubel-Moenen, F. (2026). A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges – A case report. Research and practice in thrombosis and haemostasis, 10(5), Article 106867. https://doi.org/10.1016/j.rpth.2026.106867

Franssen, I. S., de Jong, M. J., Visseren, L., Teerds, D., Hellenbrand, D., Henskens, Y., Spronk, H., Janssen, D. J. A., Braeken, D. C. W., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). The DOAC-FRAIL Study-Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents. Journal of the American Geriatrics Society. Advance online publication. https://doi.org/10.1111/jgs.70559

Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723

Urlings, E. H., Heubel-Moenen, F. C. J. I., van Oerle, R., Hellenbrand, D. L. S., van der Meijden, P. E. J., Hackeng, T. M., Cate, H. T., Nagy, M., Henskens, Y. M. C., & Spronk, H. M. H. (2026). Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. Research and practice in thrombosis and haemostasis, 10(4), Article 106627. https://doi.org/10.1016/j.rpth.2026.106627

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Brys, A. D. H., Braeken, D. C. W., van Kuijk, S. M. J., Spronk, H. M. H., Bosman, H., Janssen, D. J. A., van Geel, R. M. J. M., Hellenbrand, D., ten Cate, H., & Henskens, Y. (2026). Assessing the efficacy of a single-cycle measurement and adjustment strategy for direct oral anticoagulants in frail older patients: rationale and design of the DOAC-FRAIL randomized controlled trial. Research and practice in thrombosis and haemostasis, 10(4), Article 106800. https://doi.org/10.1016/j.rpth.2026.106800

Franssen, I. S., Jong, M. J. D., Vievermans, A., Stroo, J. F., Henskens, Y. M. C., Spronk, H., Janssen, D. J. A., Braeken, D., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). Adequacy of Direct Oral Anticoagulant Dosing in Nursing Home Residents: Cross-Sectional Data From the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 27(4), Article 106082. https://doi.org/10.1016/j.jamda.2025.106082